Tumor fluoro-2-deoxy-d-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma-Reference-Cited by-同舟云学术

Tumor fluoro-2-deoxy-d-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma

Published:2006-11 Issue:5 Volume:132 Page:1189-1195
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Raz Dan J.,Odisho Anobel Y.,Franc Benjamin L.,Jablons David M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference28 articles.

1. Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma;Carretta;Eur J Cardiothorac Surg,2001

2. Bronchoalveolar carcinoma: histopathologic study of evolution in a series of 105 surgically treated patients;Dumont;Chest,1998

3. Prognosis and recurrent patterns in bronchioloalveolar carcinoma;Liu;Chest,2000

4. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer;Miller;J Clin Oncol,2004

5. Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival;Furak;Eur J Cardiothorac Surg,2003

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of preoperative PET/computer tomography 18F-fluorodeoxyglucose uptake (maximum standardized uptake value) with prognosis in patients with operated lung cancer;Nuclear Medicine Communications;2022-02-14

2. Oncologic Outcomes of Surgery Versus SBRT for Non–Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis;Clinical Lung Cancer;2021-05

3. Diagnostic Applications of Nuclear Medicine: Lung and Mediastinal Tumors;Nuclear Oncology;2017

4. Diagnostic Applications of Nuclear Medicine: Lung and Mediastinal Tumors;Nuclear Oncology;2017

5. PET Imaging-Based Phenotyping as a Predictive Biomarker of Response to Tyrosine Kinase Inhibitor Therapy in Non-small Cell Lung Cancer: Are We There Yet?;Nuclear Medicine and Molecular Imaging;2016-10-11